These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 19582140)

  • 21. Immunodepression induced by Trypanosoma cruzi and mouse hepatitis virus type 3 is associated with thymus apoptosis.
    Verinaud L; Da Cruz-Höfling MA; Sakurada JK; Rangel HA; Vassallo J; Wakelin D; Sewell HF; Camargo IJ
    Clin Diagn Lab Immunol; 1998 Mar; 5(2):186-91. PubMed ID: 9521141
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suppression by Trypanosoma cruzi of T-cell receptor expression by activated human lymphocytes.
    Sztein MB; Kierszenbaum F
    Immunology; 1992 Oct; 77(2):277-83. PubMed ID: 1427979
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trypanosoma cruzi-induced molecular mimicry and Chagas' disease.
    Gironès N; Cuervo H; Fresno M
    Curr Top Microbiol Immunol; 2005; 296():89-123. PubMed ID: 16323421
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trypanosoma cruzi: transfer of protection by lymph node cells obtained from mice immunized with exoantigens of pI 4.5.
    Gruppi A; Cerban F; Pistoresi-Palencia MC; Vottero-Cima E
    Exp Parasitol; 1995 May; 80(3):382-9. PubMed ID: 7537218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Experimental Chagas disease in Balb/c mice previously vaccinated with T. rangeli. II. The innate immune response shows immunological memory: reality or fiction?
    Basso B; Marini V
    Immunobiology; 2015 Mar; 220(3):428-36. PubMed ID: 25454810
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trypanosoma cruzi Experimental Infection Impacts on the Thymic Regulatory T Cell Compartment.
    González FB; Calmon-Hamaty F; Nô Seara Cordeiro S; Fernández Bussy R; Spinelli SV; D'Attilio L; Bottasso O; Savino W; Cotta-de-Almeida V; Villar SR; Pérez AR
    PLoS Negl Trop Dis; 2016 Jan; 10(1):e0004285. PubMed ID: 26745276
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cellular immunity in chronic Chagas' disease.
    Montufar OM; Musatti CC; Mendes E; Mendes NF
    J Clin Microbiol; 1977 Apr; 5(4):401-4. PubMed ID: 404317
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of Human CD11b
    Passos LSA; Magalhães LMD; Soares RP; Marques AF; Alves MLR; Giunchetti RC; Nunes MDCP; Gollob KJ; Dutra WO
    Front Immunol; 2018; 9():3015. PubMed ID: 30662439
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trypanosoma cruzi trans-sialidase potentiates T cell activation through antigen-presenting cells: role of IL-6 and Bruton's tyrosine kinase.
    Gao W; Pereira MA
    Eur J Immunol; 2001 May; 31(5):1503-12. PubMed ID: 11465107
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of Intrathymic Sphingosine-1-Phosphate Levels Promotes Escape of Immature Thymocytes to the Periphery with a Potential Proinflammatory Role in Chagas Disease.
    Flávia Nardy A; Santos L; Freire-de-Lima CG; Morrot A
    Biomed Res Int; 2015; 2015():709846. PubMed ID: 26347020
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acquired cell-mediated immunodepression in acute Chagas' disease.
    Teixeira AR; Teixeira G; Macêdo V; Prata A
    J Clin Invest; 1978 Dec; 62(6):1132-41. PubMed ID: 107195
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kinetic analysis of antigen-specific immune responses in resistant and susceptible mice during infection with Trypanosoma cruzi.
    Hoft DF; Lynch RG; Kirchhoff LV
    J Immunol; 1993 Dec; 151(12):7038-47. PubMed ID: 8258708
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of the thymus in modulating gammadelta T cell suppressor activity during experimental Trypanosoma cruzi infection.
    Cardillo F; Nomizo A; Mengel J
    Int Immunol; 1998 Feb; 10(2):107-16. PubMed ID: 9533438
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human B cells infected by Trypanosoma cruzi undergo F-actin disruption and cell death via caspase-7 activation and cleavage of phospholipase Cγ1.
    Dos Santos MA; Alves Martins F; Borges BC; de Gouveia Santos J; Nascimento Alves R; Dias MH; BrígidoTavares PC; E Silva Brígido RT; Teixeira TL; Costa Rodrigues C; Cota Teixeira S; da Costa MS; da Silva AA; Barbosa Silva MJ; de Melo Rodrigues Ávila V; Patriarca Mineo TW; de Souza MA; Bahia D; da Silva CV
    Immunobiology; 2020 May; 225(3):151904. PubMed ID: 31959539
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of Trypanosoma cruzi egress from infected fibroblasts is mediated by CD4+ and mu+ immune cells.
    Rowland EC; Chen Z
    J Parasitol; 2003 Aug; 89(4):733-7. PubMed ID: 14533683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. On evasion of Trypanosoma cruzi from the host immune response. Lymphoproliferative responses to trypanosomal antigens during acute and chronic experimental Chagas' disease.
    Kierszenbaum F
    Immunology; 1981 Nov; 44(3):641-8. PubMed ID: 6797934
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of heterologous anti-thymocyte serum upon the course of infection with Trypanosoma cruzi in Mice.
    Vilches AM; Katzin A; Golfera H; Schmunis GA
    Z Tropenmed Parasitol; 1973 Sep; 24(3):279-84. PubMed ID: 4200671
    [No Abstract]   [Full Text] [Related]  

  • 38. Caspase inhibition reduces lymphocyte apoptosis and improves host immune responses to Trypanosoma cruzi infection.
    Silva EM; Guillermo LV; Ribeiro-Gomes FL; De Meis J; Nunes MP; Senra JF; Soares MB; DosReis GA; Lopes MF
    Eur J Immunol; 2007 Mar; 37(3):738-46. PubMed ID: 17295391
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunosuppression in Experimental Chagas Disease Is Mediated by an Alteration of Bone Marrow Stromal Cell Function During the Acute Phase of Infection.
    Müller U; Schaub GA; Mossmann H; Köhler G; Carsetti R; Hölscher C
    Front Immunol; 2018; 9():2794. PubMed ID: 30619242
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of Aryl Hydrocarbon Receptor (AhR) in the Regulation of Immunity and Immunopathology During
    Ambrosio LF; Insfran C; Volpini X; Acosta Rodriguez E; Serra HM; Quintana FJ; Cervi L; Motrán CC
    Front Immunol; 2019; 10():631. PubMed ID: 30984194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.